Introduction: rosuvastatin--an efficacy assessment based on pooled trial data

Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

JAMA cardiology·2026

Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial.

The lancet. Diabetes & endocrinology·2025

Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial.

JAMA cardiology·2024

Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials.

Journal of clinical lipidology·2022

LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.

Atherosclerosis·2021

Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.

Arteriosclerosis, thrombosis, and vascular biology·2020

Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population.

The American journal of cardiology·2026

Screening for Transthyretin Amyloidosis during Carpal Tunnel release: An opportunity for Early Diagnosis.

The American journal of cardiology·2026

Patients with patent foramen ovale or atrial septal defect have worse outcomes after pulmonary vein isolation.

The American journal of cardiology·2026

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026

Drug-Coated Balloons Versus Drug-Eluting Stents Following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-analysis.

The American journal of cardiology·2026

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026

Exploring the Distinct Regulatory Actions and Molecular Pathways of Coptisine Through Network Pharmacology: Insights Into Its Influence on Platelet Activation and Thrombus Development.

Food science & nutrition·2026

Effect of Betahistine on Daytime Sedation and Metabolic Parameters in Patients with Schizophrenia on Second-generation Antipsychotics.

Indian journal of psychological medicine·2026

Adult dual and polytobacco use in the United States: Findings from the 2021-2023 National Survey on Drug Use and Health.

Preventive medicine reports·2026

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Following Orthopedic Shoulder Surgery: A Comparative Analysis.

Cureus·2026

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Are Associated With Reduced Early but Increased Chronic Postoperative Opioid Use After Shoulder Surgery.

Cureus·2026

Simvastatin modulates sleep-wake behavior and locomotor activity in a dose-dependent manner in <i>Drosophila</i>.

Frontiers in pharmacology·2026

Related Experiment Videos

Introduction: rosuvastatin--an efficacy assessment based on pooled trial data

Related Concept Videos

Response to PCSK9 Inhibition Based on LDL Receptor Function in Familial Hypercholesterolemia: A Nonrandomized Clinical Trial.

Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial.

Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial.

Time-averaged low-density lipoprotein cholesterol lowering with evolocumab: Pooled analysis of phase 2 trials.

LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial.

Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program.

Anticoagulant regimen for non-valvular atrial fibrillation in the elderly and frail population.

Screening for Transthyretin Amyloidosis during Carpal Tunnel release: An opportunity for Early Diagnosis.

Patients with patent foramen ovale or atrial septal defect have worse outcomes after pulmonary vein isolation.

Balloon-Expandable Versus Self-Expanding Valves in Patients With Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

Drug-Coated Balloons Versus Drug-Eluting Stents Following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-analysis.

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Exploring the Distinct Regulatory Actions and Molecular Pathways of Coptisine Through Network Pharmacology: Insights Into Its Influence on Platelet Activation and Thrombus Development.

Effect of Betahistine on Daytime Sedation and Metabolic Parameters in Patients with Schizophrenia on Second-generation Antipsychotics.

Adult dual and polytobacco use in the United States: Findings from the 2021-2023 National Survey on Drug Use and Health.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Following Orthopedic Shoulder Surgery: A Comparative Analysis.

Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Are Associated With Reduced Early but Increased Chronic Postoperative Opioid Use After Shoulder Surgery.

Simvastatin modulates sleep-wake behavior and locomotor activity in a dose-dependent manner in <i>Drosophila</i>.

Related Experiment Videos

Introduction: rosuvastatin--an efficacy assessment based on pooled trial data

Related Concept Videos

Related Articles